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The most highly conserved noncoding ele-
ments (HCNEs) in mammalian genomes cluster
within regions enriched for genes encoding de-
velopmentally important transcription factors
(TFs). This suggests that HCNE-rich regions
may contain key regulatory controls involved
in development. We explored this by examining
histone methylation in mouse embryonic stem
(ES) cells across 56 large HCNE-rich loci. We
identified a specific modification pattern,
termed ‘‘bivalent domains,’’ consisting of large
regions of H3 lysine 27 methylation harboring
smaller regions of H3 lysine 4methylation. Biva-
lent domains tend to coincide with TF genes ex-
pressed at low levels. We propose that bivalent
domains silence developmental genes in ES
cells while keeping them poised for activation.
We also found striking correspondences be-
tween genome sequence and histone methyla-
tion in ES cells, which become notably weaker
in differentiated cells. These results highlight
the importance of DNA sequence in defining
the initial epigenetic landscape and suggest
a novel chromatin-based mechanism for main-
taining pluripotency.
INTRODUCTION
Epigenetic regulation of gene expression is mediated in
part by posttranslational modifications of histone proteins,which in turn modulate chromatin structure (Jenuwein and
Allis, 2001; Margueron et al., 2005). The core histones
H2A, H2B, H3, and H4 are subject to dozens of different
modifications, including acetylation, methylation, and
phosphorylation. Histone H3 lysine 4 (Lys4) and lysine
27 (Lys27) methylation are of particular interest as these
modifications are catalyzed, respectively, by trithorax-
and Polycomb-group proteins, which mediate mitotic in-
heritance of lineage-specific gene expression programs
and have key developmental functions (Ringrose and
Paro, 2004). Lys4 methylation positively regulates tran-
scription by recruiting nucleosome remodeling enzymes
and histone acetylases (Santos-Rosa et al., 2003; Pray-
Grant et al., 2005; Sims et al., 2005; Wysocka et al.,
2005), while Lys27 methylation negatively regulates tran-
scription by promoting a compact chromatin structure
(Francis et al., 2004; Ringrose et al., 2004).
Various observations suggest that chromatin undergoes
important alterations during mammalian development
(Delaval and Feil, 2004; Margueron et al., 2005; Sado and
Ferguson-Smith, 2005). Embryonic stem (ES) cell differen-
tiation is accompanied by changes in chromatin accessi-
bility at several key developmental genes, including a
large-scale opening of the HoxB locus (Chambeyron and
Bickmore, 2004; Perry et al., 2004). Furthermore, Poly-
comb-group proteins play an essential role in maintaining
the pluripotent state of ES cells and show markedly re-
duced expression upon differentiation (O’Carroll et al.,
2001; Silva et al., 2003; Valk-Lingbeek et al., 2004). How-
ever, little is known about the overall structure of ES cell
chromatin, how it is established, or how it contributes to
the maintenance of pluripotency (Szutorisz and Dillon,
2005).
Large-scale studies of mammalian chromatin have
recently become possible with the combination ofCell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 315
chromatin immunoprecipitation (ChIP) and DNA microar-
rays. Initial studies in primary fibroblasts revealed thou-
sands of genomic sites associated with Lys4 methylation
(Bernstein et al., 2005; Kim et al., 2005). The vast majority
show a ‘‘punctate’’ pattern, typically occurring at sites of
1-2 kb near promoters of active genes. Lys27 methyla-
tion is implicated in X chromosome inactivation and im-
printing (Plath et al., 2003; Umlauf et al., 2004). However,
little is known about the overall genomic distribution of this
repressive mark. Gene-specific and limited microarray
studies have reported that Lys27 methylation tends to oc-
cur at punctate sites near promoters of repressed genes
(Cao and Zhang, 2004; Kimura et al., 2004; Kirmizis
et al., 2004; Koyanagi et al., 2005). Based on such studies,
the distributions of Lys4 and Lys27methylation have been
thought to be nonoverlapping.
A notable exception to the punctate pattern of histone
modifications is evident at the Hox gene clusters: These
loci contain large, cell type-specific Lys4 methylated re-
gions, up to 60 kb in length, that overlay multiple Hox
genes (Bernstein et al., 2005; Guenther et al., 2005). These
regions likely reflect accessible chromatin domains estab-
lished during embryonic development to maintain Hox
gene expression programs (Chambeyron and Bickmore,
2004). However, the extent to which large domains of
chromatin modifications represent a general feature of
mammalian genomes remains unclear.
Recent studies have revealed that the most highly
conserved noncoding elements (HCNEs) in mammalian
genomes cluster within 200 HCNE-rich genomic loci,
which include all four Hox clusters (Nobrega et al., 2003;
Bejerano et al., 2004; Lindblad-Toh et al., 2005; Woolfe
et al., 2005). These regions tend to be gene-poor but are
highly enriched for genes encoding transcription factors
(TFs) implicated in embryonic development.
These findings suggest that the HCNE-rich regions or
the TF genes within them may contain key epigenetic reg-
ulatory controls involved in development. We explored
this by mapping histone methylation patterns in mouse
ES cells across 61 large regions (2.5% of the genome).
The results reveal a novel chromatin modification pattern
that we term ‘‘bivalent domains,’’ consisting of large re-
gions of Lys27 methylation harboring smaller regions of
Lys4 methylation. In ES cells, bivalent domains frequently
overlay developmental TF genes expressed at very low
levels. Bivalent domains tend to resolve during ES cell dif-
ferentiation and, in differentiated cells, developmental
genes are typically marked by broad regions selectively
enriched for either Lys27 or Lys4 methylation. We suggest
that bivalent domains silence developmental genes in ES
cells while keeping them poised for activation. Finally, we
analyzed the relationship between histone methylation
and the underlying DNA sequence in both ES and differen-
tiated cells. This analysis suggests that DNA sequence
largely defines the initial epigenetic state in ES cells, which
is subsequently altered upon differentiation, presumably
in response to lineage-specific gene expression programs
and environmental cues.316 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.RESULTS
Bivalent Domains in ES Cells Contain Repressive
and Activating Histone Modifications
Histone H3 Lys4 and Lys27 methylation patterns in ES
cells were examined across a subset of HCNE-rich loci us-
ing a combination of ChIP and tiling oligonucleotide ar-
rays. The arrays tile 61 large genomic regions, totaling
60.3 Mb, at a density of approximately one probe per 30
bases (Table S1). The regions consist of the four Hox clus-
ters (1.3 Mb encoding 43 genes), 52 additional HCNE-rich
regions (55 Mb encoding 169 genes), and five ‘‘control’’
regions that do not show high HCNE density (4 Mb encod-
ing 95 genes). We isolated genomic DNA associated with
either trimethylated Lys4 or trimethylated Lys27 by immu-
noprecipitating cross-linked chromatin, and we then hy-
bridized these DNA fractions to the tiling arrays (see Ex-
perimental Procedures). We identified regions of Lys4 or
Lys27 methylation by comparing these hybridization re-
sults to those obtained for total genomic DNA. Experi-
ments were performed in duplicate and analyzed using
previously validated criteria (Bernstein et al., 2005). The
resulting maps of ES cell chromatin (Figures 1 and S1)
show a number of important features, many of which
were unexpected.
We found a total of 343 sites of Lys4 methylation, rang-
ing in size from 1 kb to 14 kb with a median size of 3.4 kb
(Table S2). Of these, 63%correspond to transcription start
sites (TSSs) of known genes. Conversely, 80%of the TSSs
are covered by Lys4 sites. Because Lys4 sites and TSSs
each cover only2%of the genomic regions, this concor-
dance is highly significant. We and others have previously
noted a global concordance between Lys4-methylated
sites and TSSs in differentiated mammalian cells (Bern-
stein et al., 2005; Kim et al., 2005).
We also found 192 Lys27-methylated sites across these
regions. These tend to affect much larger genomic regions
than the Lys4 sites. The median Lys27 site is smaller in the
control regions (5 kb) but twice as large in the HCNE-rich
regions (10 kb) and still larger in the Hox regions (18 kb).
Overall, 75%of Lys27 sites are larger than 5 kb.Wewill re-
fer to these large regions as ‘‘Lys27 domains.’’ There are
123 in the HCNE regions, 14 in the Hox regions, and 7 in
the control regions (Table S2).
Comparison of the two datasets revealed many in-
stances of a previously undescribed pattern of chromatin
modifications: Three-quarters of the Lys27 domains con-
tain Lys4 sites within them. These regions thus harbor
both a ‘‘repressive’’ and an ‘‘activating’’ chromatin modifi-
cation; we therefore termed them ‘‘bivalent domains.’’
There are 95 in the HCNE regions, 9 in the Hox regions,
and 5 in the control regions (Table S2).
Bivalent Domains Overlay Developmentally
Important TF Genes in HCNE-Rich Regions
Roughly three-quarters of the bivalent domains in the
HCNE regions (69/95) overlap TSSs of known genes,
with the Lys4 sites typically positioned directly at the
Figure 1. Representative Views of Histone Methylation Patterns across HCNE-Rich Regions in ES and Differentiated Cells
(A)Dlx1-Dlx2genecluster (Region47,112kb). Foreachcell type, tracksshowregionsassociatedwithLys27methylation (yellow), Lys4methylation (green),
orbothmodifications (red).ForEScells only, the rawp-valuesignals for Lys27 (yellow) andLys4methylation (green)arealsoshown.Genes (TSSs indicated
by long vertical lines; exons indicated as dark), CpG islands, HCNEs (Lindblad-Toh et al., 2005), and transposable elements are also shown.
(B) En2, Shh, Hlxb9 (Region 48, 1.5 MB). Expanded views show 75 kb around each gene.
(C) Ebf1 (Region 31, 497 kb). Note expansive Lys27 methylated region in the Neuro2a cells.Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 317
Figure 2. Histone Methylation Status of
Transcription Start Sites
Methylation status is shown for the 332 known
TSSs in the 61 examined regions in ES cells,
C2C12 myoblasts, Neuro2a neuroblastoma
cells, mouse embryonic fibroblasts (MEF),
and mouse lung fibroblasts (MLF). Red indi-
cates the presence of a bivalent domain; yellow
indicates Lys27 methylation only; green indi-
cates Lys4 methylation only; and black indi-
cates no detected methylation. Blue rows in
the three rightmost columns indicate TSSs
that correspond to TF genes, contain CpG is-
lands, or coincide with transposon-exclusion
zones (TEZs). This figure and the correspond-
ing Table S3 show the strong correlation
among bivalent domains, TF genes, CpG
islands, and TEZs.TSS. Of these, a full 93% (64/69) occur at genes that en-
code TFs, including Sox, Fox, Pax, Irx, and Pou gene fam-
ily members, even though TF genes make up only half of
the genes in the regions examined (Figure 2). The 26 biva-
lent domains that do not occur at known TSSs are also of
interest: Four occur at the 30-ends of developmental genes
(Npas3, Meis2, Pax2, and Wnt8b), and ten occur in loca-
tions that show strong evidence of encoding transcripts
(including the presence ofmRNA transcripts, CpG islands,
and high levels of sequence conservation). Among the
nonTF genes associated with bivalent domains are genes
implicated in neural development, such as Fgf8 and
Prok1. In the Hox regions, the observed bivalent domains
are especially large and overlap multiple TSSs of known
genes, all of which are TFs. The five bivalent domains in
the control regions are quite short; they all overlap gene
starts, although these genes do not encode TFs.318 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.The chromatin analysis thus reveals that ES cells con-
tain many bivalent domains. In HCNE-rich regions, these
domains are particularly large and highly enriched at de-
velopmentally important genes that establish cell identity.
The bivalent nature of this novel epigenetic pattern raises
the possibility that the associated genes are poised in a bi-
potential state, which may be resolved differently in differ-
ent cell lineages. This hypothesis predicts that differenti-
ated cells would contain few, if any, bivalent domains.
In Differentiated Cells, TF Genes Are Marked
by Either Repressive or Activating Modifications
We next examined Lys4 and Lys27 methylation patterns
across these same regions in a collection of differentiated
cell types, including mouse embryonic fibroblasts (MEFs),
mouse primary lung fibroblasts (MLFs), C2C12myoblasts,
and Neuro2a neuroblastoma cells. We identified multiple
Lys4 and Lys27methylated sites in each cell type, many of
which are large. However, in marked contrast to the ES
cell data, we found few bivalent domains in the differenti-
ated cells (6 in MEFs, 1 inMLFs, 13 in myoblasts, and 12 in
the neuroblastoma cells).
Thus, the majority of TSSs that show bivalent domains
in ES cells do not show bivalent domains in the differenti-
ated cells. The vast majority of these (93/97) instead show
either a Lys27- or a Lys4-methylated site in at least one of
the differentiated cell types (Figure 2 and Table S3). These
‘‘monovalent’’ sites tend to be large, with median sizes of
19.4 kb and 7.4 kb for Lys27 and Lys4, respectively (com-
pared to 6.7 kb and 3.4 kb over all sites in the differentiated
cells). Thus, bivalent domains appear largely specific to
ES cells and, in differentiated cells, developmental genes
are instead frequently organized within expansive regions
showing either repressive or activating modifications.
Bivalent Modification Patterns in ES Cells Confirmed
by Alternate Techniques
Given the novel nature of the bivalent domains, we sought
to confirm our results using completely different reagents
and protocols (see Experimental Procedures). Specifi-
cally, we used an independent source of ES cellswith a dif-
ferent genotype; we refer to the first source as ES1 and the
second as ES2. We also used an alternative ChIP proce-
dure carried out onmicrococcal nuclease-digested nucle-
osomes that had not been subjected to cross-linking and
performed the immunoprecipitation with antisera from dif-
ferent sources. This alternative ChIP technique controls
for nucleosome occupancy and is not subject to potential
artifacts of cross-linking and sonication (O’Neill and
Turner, 2003). The ES2 data also show a large number
of bivalent domains, and these correspond closely to
those seen in the ES1 data. Importantly, 94 of the 95 biva-
lent domains in the ES2 data correspond to bivalent do-
mains in the ES1 cells.
We next sought to test whether the observed bivalent
domain structure truly reflects the simultaneous presence
of both Lys4 and Lys27 methylation on the same physical
chromosomes. It is formally possible that the bivalent do-
mains could instead reflect the presence of either two
subpopulations with distinct character or one population
alternating between two states. To rule out this possibility,
we carried out a sequential ChIP in which ES cell chroma-
tin was immunoprecipitated first with Lys27 tri-methyl an-
tibody and second with Lys4 tri-methyl antibody. This se-
quential purification is designed to retain only chromatin
that concomitantly carries both kinds of modifications.
Using real-time PCR, we tested three TSSs associated
with bivalent domains (Irx2, Dlx1, and Hlxb9). Each was
significantly enriched relative to the controls (genes en-
riched for only Lys27 or only Lys4) (see Figure 3 and Ex-
perimental Procedures). For example, Irx2 is enriched
10-fold in the primary (Lys27) ChIP and further enriched
>30-fold (relative to control) in the secondary (Lys4) ChIP.
This shows that a large proportion of Irx2 chromatin that
contains Lys27 methylation also contains Lys4 methyla-tion—at least 30-fold more than the control. (Of course,
the technique cannot prove that 100% of all Irx2 species
in ES cells carry both modifications because of inherent
limitations due to background). We also tested the Irx2
TSS by repeating the sequential ChIP with the order of
the immunoprecipitations reversed and again found sig-
nificant enrichment (see Experimental Procedures). To-
gether, the experiments above suggest that the bivalent
domains accurately represent the epigenetic state at
many TF genes in ES cells.
Bivalent Domains Are Associated with Low Levels
of Gene Expression
To gain insight into the functional significance of bivalent
domains, we examined gene expression patterns across
the three cell types with at least ten bivalent domains (ES
cells, C2C12, andNeuro2a) (Mogass et al., 2004; Tomczak
et al., 2004; Perez-Iratxeta et al., 2005). Within each cell
type, we found that genes marked by Lys4 methylation
tend to be expressed at significantly higher levels than
those associated with Lys27 methylation (Figure 4). A
good example is the Ebf1 gene, which encodes a TF impli-
cated in multiple differentiation pathways: In MEFs, MLFs,
and myoblasts, it is expressed at relatively high levels
(Schraets et al., 2003; Koli et al., 2004) and is associated
with relatively large Lys4 sites (>5 kb), while in neuroblas-
toma cells it is expressed at an essentially undetectable
level and is associated with an expansive Lys27 domain.
We next examined the expression levels of genes
marked by bivalent domains. These show low levels of ex-
pression, with the overall distribution being similar to that
for genes marked by Lys27 methylation alone (Figure 4).
Thus, the presence of Lys4 methylation at a TSS is typi-
cally associated with high gene activity when it occurs in
the absence of Lys27 methylation but with low gene activ-
ity when it occurs together with Lys27 methylation (that is,
the repressive effect of Lys27 appears to be epistatic to
the activating effect of Lys4 methylation in a bivalent do-
main). These results raise the possibility that bivalent do-
mains function to silence developmental genes in ES cells
while keeping them poised for induction upon initiation of
specific developmental pathways.
Resolution of Bivalent Domains during ES
Cell Differentiation
Our analysis of ES cells and four differentiated cell types
suggests that bivalent domains are characteristic of plu-
ripotent cells, that they silence developmental genes while
keeping them poised, and that they tend to resolve upon
ES cell differentiation into Lys4 or Lys27 methylation, in
accordance with associated changes in gene expression.
We sought to study whether the resolution of bivalent do-
mains can be observed soon after ES cell differentiation
by examining a differentiated cell type obtained directly
from ES cells. Specifically, we differentiated ES cells along
a neural pathway in serum-free culture and generated
a homogenous population of multipotent neural precursor
cells maintained in FGF2- and EGF-containing media, asCell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 319
Figure 3. Characterization of the Irx2 Bivalent Domain
ChIP and sequential ChIP were used to examine the methylation status of the Irx2 TSS (bivalent), the Tcf4 TSS (Lys4 only), and a site upstream of
HoxA3 (Lys27 only).
(A) Real-time PCR ratios reflect the enrichment of indicated sites when ES cells are subjected to ChIP with trimethyl Lys4 antibody or trimethyl Lys27
antibody.
(B) Corresponding data for mouse lung fibroblasts.
(C) Real-time PCR ratios reflect the relative enrichment of indicated sites after sequential immunoprecipitations with trimethyl Lys27 antibody and
then trimethyl Lys4 antibody (see Experimental Procedures).
(D) PCRproducts amplified from control (input) DNA, Lys27ChIP DNA, and Lys27-Lys4 sequential ChIP DNA are shown; the same sampleswere used
as real-time PCR template in (C). The sequential ChIP results indicate that, in ES cells, the Irx2 TSS is associatedwith chromatinmarked by both Lys27
and Lys4 methylation.described previously (Conti et al., 2005). We focused on
seven genes associated with bivalent domains in ES cells
(Figure 5). These include three genes that are markedly in-
duced during differentiation (Nkx2.2, Sox21, and Zfpm2),
one that is weakly induced (Dlx1), and three that are not in-
duced (Pax5, Lbx1h, and Evx1). Using ChIP and real-time
PCR, we first confirmed that the TSS of each gene is in-
deed associated with both Lys4 and Lys27 methylation
in the original ES cells, and we then examined the methyl-
ation status of these genes in the neural precursor cells.
For the three genes whose expression is markedly in-
duced, the TSS becomes specifically associated with
Lys4methylation in these differentiated cells. For the three
genes that are not induced, the TSS becomes specifically
associated with Lys27 methylation. Interestingly, the TSS
of the weakly induced gene, Dlx1, remains associated
with both methylation marks in the neural precursor cells,
although the Lys4 signal is significantly stronger. These320 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.data support a model in which bivalent domains are
largely specific to ES cells and tend to resolve upon ES
cell differentiation according to pathway-specific gene
expression programs.
Epigenetic Modifications in ES Cells Strongly
Correlate with Underlying DNA Sequence
Because the Lys4- and Lys27-methylated sites in ES cells
seem to represent important initial conditions for develop-
ment, we searched for DNA sequence features that might
underlie or predict the establishment of these epigenetic
marks across the genome.
We found a strong positive correlation between the
presence of Lys4 methylation in ES cells and the density
of CpG dinucleotides in the underlying DNA sequence
(median 8% versus 2% expected) (Figure S2). Strikingly,
95% of TSSs with Lys4 sites have CpG islands, and
91% of TSSs with CpG islands also have Lys4 sites
(rphi = 0.73) (see Table S4 and Experimental Procedures).
Moreover, the lengths of the two features are significantly
correlated where they overlap (r = 0.50). By contrast, the
correlation is weaker in the differentiated cells; this is pri-
marily due to loss of Lys4 methylation at 20%–35% of
CpG islands (rphi = 0.40 for MLFs) (Table S4). We note
that a recent genome-wide study (Roh et al., 2005) of his-
tone H3 acetylation in T cells observed a correlation with
CpG islands at a similar level to that seen in the differenti-
ated cells examined here.
Figure 4. Gene Expression as a Function of Histone Methyla-
tion Status
Box plot showing 25th, 50th, and 75th percentile expression levels in ES
cells, myoblasts, and neuroblastoma cells for genes associated with
no histone methylation, Lys27 methylation, bivalent domains, or Lys4
methylation. Whiskers show 2.5th and 97.5th percentiles. Expression
data (y axis) were determined from published expression profiles (Mo-
gass et al., 2004; Tomczak et al., 2004; Perez-Iratxeta et al., 2005), uni-
formly normalized to a mean of 0 and a standard deviation of 1 for all
probes on each array.
Figure 5. Resolution of Bivalent Domains during ES Cell
Differentiation
ES cells were differentiated along a neural pathway in serum-free cul-
ture, and a homogenous population of multipotent neural precursor
cells were maintained in FGF2- and EGF-containing media, as de-
scribed in Conti et al., 2005. Several loci showing bivalent domains
in ES cells were examined in the differentiated cells.
(A) Expression levels (relative to Gapdh) were determined by
RT-PCR for the indicated genes in ES cells and in neural precursors.
The methlyation states of the indicated genes were determined by
ChIP and real-time PCR in ES cells (B) and in neural precursors
(C). The data suggest that bivalent domains tend to resolve during
ES cell differentiation in accordance with associated changes in
gene expression.Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 321
Wealso found that Lys27-methylated regions in ES cells
show a strikingly low density of transposon-derived se-
quence (median 6% versus 22% expected) (Figures S2
and S3). The most extreme example is found at the Hox
clusters, which are known to have the lowest density of
transposon-derived sequence in the mouse and human
genomes (Lander et al., 2001; Waterston et al., 2002)
and which have the largest Lys27 domains (up to 141
kb) in our sample. Most of the Lys27 domains contain
long stretches (>10 kb) with little or no identifiable transpo-
son-derived sequence. We defined such regions as
‘‘transposon exclusion zones’’ (TEZs) (see Experimental
Procedures). Within the loci examined here, 89% of
TSSs with a TEZ have a Lys27 domain in ES cells, and
73% of TSSs with a Lys27 domain have a TEZ (rphi =
0.69) (Table S4). The lengths of these two features are sig-
nificantly correlated where they overlap (r = 0.78). Interest-
ingly, we note that the small number of Lys27 domains
found only in differentiated cells does not appear to over-
lap particularly transposon-poor sequence (Figure 1C and
Table S4).
We tested if the TEZs represent conserved genomic
features by examining the orthologous sequence in the
human and dog genome. The frequency of lineage-spe-
cific repeats provides an independent test of whether
transposons are tolerated in these regions. The TEZs
show a clear deficit of lineage-specific repeats in both hu-
man (1.3% versus 15.2%expected) and dog (1.0% versus
9.1% expected), confirming that this property is strongly
conserved across mammals.
We then searched for TEZs across the entire mouse ge-
nome. We identified 710 TEZs, of which 328 overlap TSSs
of known genes (Table S5). Strikingly, the vast majority of
these genes encode developmental and tissue-specific
TFs (189), proteins involved in axon guidance and neuro-
nal function (65), and other cell signaling-related proteins
such as growth factors (25), including Fgf8, Fgf10,
Fgf14, and the imprinted gene Igf2. Notably, they include
70% of the developmental regulators previously identi-
fied within 204 HCNE-rich loci (Lindblad-Toh et al.,
2005). We predict that most of these genes will harbor
Lys27 domains or bivalent domains in ES cells.
Colocalization of Bivalent Domains with Oct4
and Nanog
Finally, we examined the relationship of bivalent domains
to the reported binding sites of certain pluripotent TFs. A
recent genomic analysis in human ES cells found that
Oct4, Nanog, and Sox2 are frequently associated with de-
velopmentally important genes (Boyer et al., 2005). We
mapped the Oct4, Nanog, and Sox2 binding sites re-
ported in that study to orthologous positions in the mouse
genome and examined their overlap with bivalent do-
mains. About 50%of bivalent domains coincide with bind-
ing sites of at least one of the pluripotent TFs, a highly sig-
nificant correspondence (p < 109). The correlation is
primarily due to Oct4 and Nanog and actually becomes
more significant when Sox2 is removed from the analysis.322 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.Interestingly, although many of the genes targeted by
these pluripotent factors are actively expressed in ES
cells, those that are also associated with a bivalent do-
main tend to be silenced (p < 5  103). This suggests
that the bivalent domains may override any activation po-
tential these TFs might have but also raises the possibility
that the pluripotent TFs may help keep these genes in
a poised state. Notably, a full 50% of bivalent domains
are not associated with any of the three pluripotent TFs.
It will be interesting to see if these coincide with binding
sites of other important TFs.
DISCUSSION
Our results shed light on chromatin structure in ES cells
and raise intriguing hypotheses about its establishment
and function during development. The bivalent domains
reported here have many notable features: They combine
both ‘‘repressive’’ and ‘‘activating’’ modifications; they are
highly enriched in ES cells relative to differentiated cells;
and they are associated with genes encoding TFs with
roles in embryonic development and lineage specification.
In differentiated cells, these TF genes instead tend to be
associated with large regions carrying either an activating
or a repressive methylation mark. We propose that biva-
lent domains silence developmental genes in ES cells
while preserving their potential to become activated
upon initiation of specific differentiation programs. Biva-
lent domains may be related to a phenomenon observed
at the bithorax complex in early fly development, where si-
lenced Polycomb response elements are nonetheless as-
sociated with trithorax-group proteins and low-level tran-
scription. Remarkably, both of these activities appear to
be required for subsequent gene activation during devel-
opment (Orlando et al., 1998; Schmitt et al., 2005). By
analogy, Lys4methylation within bivalent domains and as-
sociated trithorax activities may keep silenced develop-
mental genes poised in ES cells. Our analyses of differen-
tiated cells suggest that bivalent domains largely resolve
during differentiation into large regions of either Lys27 or
Lys4 methylation. These modified regions may provide
a robust epigenetic memory to maintain lineage-specific
expression or repression of these critical genes. Their
large size would ensure that each daughter chromosome
would likely inherit a substantial proportion of themodified
histones, which could then promote similarmodification of
new histones in the immediate vicinity (Henikoff et al.,
2004; van Steensel, 2005).
A fundamental issue that remains is to understand the
mechanism by which the initial conditions are estab-
lished in ES cells. The analysis here suggests that
some of the answer can be read directly from the ge-
nome sequence. The strong association of Lys4 methyl-
ation with CpG islands may well be directly causal, inas-
much as the trithorax complexes that methylate Lys4 are
reported to associate with CpG-rich DNA (Ayton et al.,
2004; Lee and Skalnik, 2005). The strong association of
Lys27 methylation with transposon-exclusion zones
may instead reflect strong evolutionary pressure against
the presence of transposon-derived sequence in these
regions. Repetitive sequences are subject to repressive
epigenetic modifications (Arnaud et al., 2000; Lippman
et al., 2004; Martens et al., 2005), which might interfere
with the function of the bivalent domains and thus be
eliminated by selection. It has been reported previously
that imprinted loci, while significantly depleted for short
interspersed transposable elements (SINEs), are permis-
sive to L1 long interspersed transposable elements
(LINEs) (Greally, 2002). In contrast, we find that both
classes of transposons tend to be excluded from regions
associated with Lys27 methylation or bivalent domains in
ES cells. The direct signal for Lys27 methylation remains
unclear (although we cannot exclude the possibility that
the deficit of transposon-related chromatin modifications
in some fashion promotes the association of the Poly-
comb complex that methylates Lys27). The correlations
between the histone modifications and the genomic fea-
tures are notably weaker in differentiated cells (Bernstein
et al., 2005). We suggest that while the embryonic state
may be largely defined by DNA sequence, it is subse-
quently altered in response to lineage-specific transcrip-
tional programs and environmental cues and epigeneti-
cally maintained.
Our study was motivated by the suspicion that HCNE-
rich regions might be particularly fruitful targets for study-
ing chromatin structure in ES cells; this has indeed been
borne out. However, the results here do not explain the
functional role of the HCNEs themselves. Although
HCNEs are markedly enriched at many of the Lys27 and
Lys4 sites in both ES and differentiated cells, they tend
overall to be distributed across much larger regions.
One possibility is that some of the HCNEs dictate chromo-
some conformation or nuclear localization in a manner
that facilitates robust gene regulation and/or epigenetic
switching (Chambeyron and Bickmore, 2004; Kosak and
Groudine, 2004).
Further studies will be needed to define bivalent do-
mains and related features. It will be important to examine
the entire genome in ES cells as well as to follow their fate
during development and differentiation. In particular, it will
be interesting to determine whether the bivalent domains
that persist following ES cell differentiation correspond to
genes that remain poised for later induction. In addition, it
will be valuable to characterize the bivalent domains with
respect to other epigenetic modifications and the binding
sites of additional TFs. We note that preliminary studies of
H3 Lys9methylation show no evidence of association with
bivalent domains.
A deeper understanding of bivalent domains may shed
light on mechanisms that underlie the maintenance of plu-
ripotency in ES cells and lineage fidelity in differentiated
cells. Moreover, a comprehensive inventory of the pres-
ence or absence of bivalent domains over key develop-
mental genesmay provide valuablemarkers of cell identity
and differentiation potential, both in normal and patho-
logic states.EXPERIMENTAL PROCEDURES
Cell Culture
The first source of ES cells (ES1) were V6.5 murine ES cells (genotype
129SvJae C57BL/6; male; passages 10–15). They were cultivated in
5% CO2 at 37º on irradiated MEFs in DMEM containing 15% FCS, leu-
kemia-inhibiting factor, penicillin/streptomycin, L-glutamine, and non-
essential amino acids (Rideout et al., 2000). At least two to three pas-
sages under feeder-free conditions on 0.2% gelatin were used to
exclude feeder contamination. The second source of ES cells (ES2,
used for micrococcal nuclease-ChIP) was SF1-1 murine ES cells (ge-
notype C57BL/6  M. spretus F1; male; passages 11–16) grown in
the absence of feeder cells on gelatinized plates as described previ-
ously (Umlauf et al., 2004). Primary mouse lung fibroblasts (ATCC
#CCL-206), mouse embryonic fibroblasts (10.5 p.c.) immortalized
with polyoma virus, C2C12 myoblasts (ATCC #CRL-1772), and Neu-
ro2a neuroblastoma cells (ATCC #CCL-131) were grown in DMEM
with 10% fetal bovine serum and penicillin/streptomycin at 37º, 5%
CO2. ES1 cells were differentiated into pan-neural precursor cells
through embryoid body formation for 4 days and selection in ITSFn
media for 5–7 days (Okabe et al., 1996), and they were maintained in
FGF2 and EGF2 (both from R&D Systems) containing chemically de-
fined media as described (Conti et al., 2005). These cells uniformly ex-
press nestin and Sox2 and upon growth factor withdrawal differentiate
into neurons, astrocytes, and oligodendrocytes (Brustle et al., 1999;
Conti et al., 2005).
Chromatin Immunoprecipitation
ChIP experiments for all cells except ES2 were carried out as de-
scribed in Bernstein et al., 2005 and at http://www.upstate.com.
Briefly, 5  107 cells were trypsinized, fixed with 1% formaldehyde,
resuspended in Lysis Buffer, and fragmented with a Branson 250 So-
nifier to a size range of 200 to 1,000 bases. Solubilized chromatin was
diluted 10-fold in ChIP dilution buffer and, after removal of a control al-
iquot, incubated at 4ºC overnight with antibody against trimethyl Lys4
(Abcam #8580) or trimethyl Lys27 (Upstate #07-449). Immune com-
plexes were precipitated with Protein A-sepharose, washed sequen-
tially with Low Salt Immune Complex Wash, LiCl Immune Complex
Wash, and TE, and then eluted in Elution Buffer. After cross-link rever-
sal and Proteinase K treatment, ChIP and control DNA samples were
extracted with phenol-chloroform, precipitated under ethanol, treated
with RNase and Calf Intestinal Alkaline Phosphatase, and purified with
a MinElute Kit (Qiagen).
Micrococcal Nuclease-ChIP
Chromatin fragments of one to six nucleosomes were prepared from
unfixed chromatin from ES2 cells by micrococcal nuclease digestion
and immunoprecipitated using antibody against trimethyl Lys27 (Plath
et al., 2003) or dimethyl Lys4 (Upstate #07-030) as described (Umlauf
et al., 2004). Immunoprecipitated DNA fractions and a control DNA
sample enriched using unrelated antisera (against chicken antibodies)
were extracted and purified as described above.
Sequential ChIP
Cross-linked chromatin from ES cells was immunoprecipitated with
antibody against trimethyl Lys27 as described above (see ‘‘Chromatin
Immunoprecipitation’’) except that chromatin was eluted in a solution
of 30 mM DTT, 500 mM NaCl, and 0.1% SDS at 37º. Eluted chromatin
was diluted 50-fold, subjected to a second immunoprecipitation with
antibody against trimethyl Lys4, and then eluted with standard Elution
Buffer. The isolated DNA was extracted and purified as above. In ad-
dition, a ‘‘reverse’’ sequential ChIP was carried out in which chromatin
was immunoprecipitated first with antibody against trimethyl Lys4 and
then with antibody against trimethyl Lys27.Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc. 323
Real-Time PCR
PCR primers for evaluating ChIP assayswere designed to amplify 150–
200 base pair fragments from the indicated genomic regions. Real-
time PCR was carried out using Quantitect SYBR green PCRmix (Qia-
gen) in an MJ Research Opticon Instrument. For ChIP experiments,
either 0.5 ng ChIP DNA or 0.5 ng control DNA was used as template,
and fold-enrichments were determined by the 2-DCTmethod described
in the Applied Biosystems User Bulletin. For sequential ChIP experi-
ments, 2 ml sequential ChIP DNA or 2 ml of a 1:100 dilution of input
DNA was used as template, and relative fold-enrichments were deter-
mined by the 2-DDCT method, using HoxA3 Ups as the normalizer.
Ratios were determined from two independent ChIP or sequential
ChIP assays, each evaluated in duplicate by real-time PCR. Primers
corresponding to the Irx2, Dlx1, or Hlxb9 TSSs were used to test for
enrichment of Lys9 methylation (see Supplemental Data). RT-PCR
was used to measure gene expression in ES cells and neural precursor
cells. Briefly, RNA was isolated using an RNeasy mini kit (Qiagen),
reverse transcribed, and quantified using SYBR green PCR master
mix on a 7000 ABI detection system. Primer sequences are available
in Supplemental Data.
Region Selection and Array Design
The identification of 204 HCNE-rich loci on the basis of sequence com-
parisons across the human, mouse, and dog genomes was reported
previously (Lindblad-Toh et al., 2005). For the current study, we se-
lected 56 HCNE-rich loci, including all four Hox clusters, as well as 5
control loci that do not show unusual HCNE density (ACTA locus, chro-
mosome 19 gene desert, CD33r locus, BRCA1 locus, cytokine cluster).
Each region was mapped to the mouse genome using mm5 coordi-
nates (Table S1). Custom tiling arrays for these regions were obtained
from Affymetrix Inc. (Santa Clara, CA). They contain approximately 1.3
million probe pairs, each consisting of perfect match (PM) and single
basemismatch (MM) 25-mer oligonucleotides, designed to interrogate
the unique sequence in these regions at approximately 30 base inter-
vals (Kapranov et al., 2002).
DNA Amplification and Array Hybridization
ChIP and control DNA samples were amplified by in vitro transcription,
converted into double-stranded cDNA with random primers, frag-
mented with DNase I, and end-labeled with biotin as described (Kap-
ranov et al., 2002; Liu et al., 2003; Cawley et al., 2004; Bernstein et al.,
2005). ChIP and control samples (5–10 mg) were hybridized to separate
oligonucleotide arrays. Arrays were hybridized 16–18 hr at 45ºC,
washed, stained, and scanned using an Affymetrix GeneChip Scanner
3000 7G as described in the Affymetrix Expression Analysis Technical
Manual.
Analysis of ChIP Tiling Array Data
Raw array data were quantile-normalized, scaled, and analyzed as de-
scribed (Cawley et al., 2004; Bernstein et al., 2005). Enrichment was
quantified using a Wilcoxon Rank Sum test applied to the transforma-
tion log2(max[PM-MM,1]) for data from ChIP and control arrays within
a window of ±500 base pairs, testing the null hypothesis that ChIP and
control data come from the same probability distribution. Genomic po-
sitions belonging to enriched regions were defined by applying a high
P-value cutoff of 104. These regions were extended locally by merg-
ing adjacent windows with P-values of at least 102, and resultant po-
sitions separated by <2 kb were merged to form a predicted Lys4 or
Lys27 methylated site. Bivalent domains were defined as Lys27 meth-
ylated regions > 5 kb that overlap Lys4 sites > 1 kb. Histone methyla-
tion data are available as interactive tracks at: http://www.broad.mit.
edu/cell/hcne_chromatin.
Genomic Analysis
We collated a list of known TSSs based on RefSeq and Genbank
mRNAs aligned to the examined regions in mouse (mm5) and the or-
thologous regions in human (hg17; alignments obtained from the324 Cell 125, 315–326, April 21, 2006 ª2006 Elsevier Inc.UCSC genome browser). The methylation status of each TSS was
based on the presence of significantly enriched Lys4 or Lys27 sites
or bivalent domains within 2 kb upstream or downstream. The ex-
pected density of CpG and transposable elements at methylated sites
was determined from random intervals of the same size, anchored in
nonrepetitive sequence. CpG islands were defined as in Takai and
Jones, 2002. TEZs (transposon exclusion zones) were defined as re-
gions satisfying one of two criteria: (1) regions of at least 10 kb without
any transposable elements; (2) regions of at least 15 kb with no more
than 250 bases annotated as transposable elements. Identified
regions were then merged together as one TEZ if they were within
1kb. For the genome-wide search, only criterion (1) was used. Supple-
mental Data are available at: http://www.broad.mit.edu/cell/hcne_
chromatin.
Supplemental Data
Supplemental Data include three figures and five tables and can be
found with this article online at http://www.cell.com/cgi/content/full/
125/2/315/DC1/.
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